Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ACTRN12626000503325) titled 'Personalised Melanoma Risk Assessment in Australian Adults Using Genetic and Clinical Information for Prevention Behaviours' on April 23.
Study Type: Interventional
Study Design:
Purpose: Prevention
Allocation: Randomised controlled trial
Masking: Open (masking not used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: The University of Queensland
Condition:
Melanoma
Melanoma
Cancer - Malignant melanoma
Intervention:
Participants will receive a personalised melanoma risk assessment based on the integration of genetic and clinical risk factors. Genetic risk will be derived from analysis of ...